TCGX
近期投资事件
更多2026-08-11
罕见血管疾病靶向疗法开发商
医药研发/制造
化学&生物药
2026-08-07
治疗药物研发商
医药研发/制造
化学&生物药
Vestal Point Capital;
Vestal Point Capital;
RTW Investments;
RTW Investments;
ADAR1 Capital Management;
Wellington Management;
Bain Capital;
TCGX
2026-08-03
细胞和基因疗法研发商
医药研发/制造
化学&生物药
Caligan Partners;
Caligan Partners;
Eventide Asset Management;
Eventide Asset Management;
八方资本;
Redmile Group;
Spruce Street Capital;
Atlas Venture;
Deep Track Capital;
Foresite Capital;
Janus Henderson Investors;
Logos Capital;
Pivotal bioVenture Partners;
RA Capital;
RTW Investments;
TCGX;
Wellington Management;
Balyasny Asset;
诺和诺德
2024-04-03
细胞和基因疗法研发商
医药研发/制造
化学&生物药
Wellington Management;
Wellington Management;
Foresite Capital;
Foresite Capital;
Janus Henderson Investors;
诺和诺德;
Paradigm BioCapital;
RTW Investments;
T. Rowe Price;
Woodline Partners;
Atlas Venture;
Blue Owl Capital;
百时美施贵宝;
Deep Track Capital;
Logos Capital;
RA Capital;
TCGX;
Surveyor Capital;
Samsara BioCapital
相关合作机构
最新投融资资讯
更多-
雷递2026-09-02
-
上海证券报2026-09-02
-
药多网2026-09-02
-
药多网2026-09-02
-
动脉网-最新2026-09-02
-
中国医药报2026-09-02
-
医药云端工作室2026-09-02
-
中国医药报2026-09-02
-
华尔街见闻2026-09-02
-
河南省肿瘤医院2026-09-02